These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 14972078)

  • 1. Do we still believe in the dopamine hypothesis? New data bring new evidence.
    Abi-Dargham A
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S1-5. PubMed ID: 14972078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent evidence for dopamine abnormalities in schizophrenia.
    Abi-Dargham A
    Eur Psychiatry; 2002 Aug; 17 Suppl 4():341s-347s. PubMed ID: 23573603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.
    Winterer G
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S68-71. PubMed ID: 16508900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hallucinations, consciousness and psychosis].
    Del Cul A; Gaillard R; Jardri R; Fossati P
    Encephale; 2010 Sep; 36(4):348-54. PubMed ID: 20850607
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of brain imaging in assessment of cognitive symptoms. Cognitive and emotional impact of antipsychotic drug treatment]].
    Martinot JL; Peretti CS
    Encephale; 2006 Jan; 32 Pt 2():S3-5. PubMed ID: 16800076
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.
    Kapur S
    Am J Psychiatry; 2003 Jan; 160(1):13-23. PubMed ID: 12505794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The dopaminergic hypothesis revisited].
    Guillin O
    Encephale; 2006 Oct; 32(5 Pt 4):S908-11; discussion S912. PubMed ID: 17119503
    [No Abstract]   [Full Text] [Related]  

  • 9. [Deficit schizophrenia: from pharmacology to clinical practice].
    Tassin JP
    Encephale; 1996 Jun; 22 Spec No 2():9-12. PubMed ID: 8767035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
    Arnsten AF; Girgis RR; Gray DL; Mailman RB
    Biol Psychiatry; 2017 Jan; 81(1):67-77. PubMed ID: 26946382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution and function of dopamine D1, D2 receptor].
    Suhara T; Miyoshi M
    Rinsho Shinkeigaku; 2007 Nov; 47(11):826-8. PubMed ID: 18210808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic dysfunction in schizophrenia: salience attribution revisited.
    Heinz A; Schlagenhauf F
    Schizophr Bull; 2010 May; 36(3):472-85. PubMed ID: 20453041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiology of dopamine in schizophrenia.
    Guillin O; Abi-Dargham A; Laruelle M
    Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
    Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
    Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine in schizophrenia: a review and reconceptualization.
    Davis KL; Kahn RS; Ko G; Davidson M
    Am J Psychiatry; 1991 Nov; 148(11):1474-86. PubMed ID: 1681750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.
    Abi-Dargham A; Moore H
    Neuroscientist; 2003 Oct; 9(5):404-16. PubMed ID: 14580124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness.
    Scornaiencki R; Cantrup R; Rushlow WJ; Rajakumar N
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1195-208. PubMed ID: 19275776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia.
    Perlstein WM; Carter CS; Noll DC; Cohen JD
    Am J Psychiatry; 2001 Jul; 158(7):1105-13. PubMed ID: 11431233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.
    Karch S; Leicht G; Giegling I; Lutz J; Kunz J; Buselmeier M; Hey P; Spörl A; Jäger L; Meindl T; Pogarell O; Möller HJ; Hegerl U; Rujescu D; Mulert C
    J Psychiatr Res; 2009 Oct; 43(15):1185-94. PubMed ID: 19426993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.
    Elsworth JD; Groman SM; Jentsch JD; Leranth C; Redmond DE; Kim JD; Diano S; Roth RH
    Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.